Literature DB >> 7737372

Apoptosis induced by c-myc overexpression is dependent on growth conditions.

A W Gibson1, T Cheng, R N Johnston.   

Abstract

Recent reports have suggested a causal link between the expression of the c-myc gene and ensuing cell death by apoptosis, particularly in cells prevented from dividing or after withdrawal of growth factors. In contrast, other studies have suggested that cells constitutively expressing c-myc are actually more resistant to cell death induced by some chemotherapeutic drugs that block cell division. We have examined the frequency of cell death in several Chinese hamster ovary cell lines that contain 20 to 30 copies of the human c-myc gene and that express high levels of human c-myc mRNA and protein. We found that constitutive c-myc expression in cells incubated at low density in medium containing 0.1% serum correlates with increased cell death due to apoptosis, as indicated by oligonucleosomal DNA fragmentation and a requirement for ongoing protein synthesis. However, apoptosis was not enhanced in these cells when they were blocked in cell division in the presence of serum, nor when grown at moderate to high density under low-serum conditions, despite their continued accumulation of high levels of c-Myc protein. Our results show that overexpression of c-Myc protein can promote cell death under some but not all conditions that block cell division and further suggest that c-Myc may accelerate but does not necessarily initiate apoptosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7737372     DOI: 10.1006/excr.1995.1166

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

Review 1.  MYC activation is a hallmark of cancer initiation and maintenance.

Authors:  Meital Gabay; Yulin Li; Dean W Felsher
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-02       Impact factor: 6.915

2.  Metformin targets c-MYC oncogene to prevent prostate cancer.

Authors:  Tunde Akinyeke; Satoko Matsumura; Xinying Wang; Yingjie Wu; Eric D Schalfer; Anjana Saxena; Wenbo Yan; Susan K Logan; Xin Li
Journal:  Carcinogenesis       Date:  2013-10-15       Impact factor: 4.944

Review 3.  Inactivation of MYC reverses tumorigenesis.

Authors:  Y Li; S C Casey; D W Felsher
Journal:  J Intern Med       Date:  2014-07       Impact factor: 8.989

4.  Establishment and characterization of multicellular spheroids from a human glioma cell line; Implications for tumor therapy.

Authors:  Divya Khaitan; Sudhir Chandna; M B Arya; B S Dwarakanath
Journal:  J Transl Med       Date:  2006-03-02       Impact factor: 5.531

5.  The transcription factor c-Myc suppresses MiR-23b and MiR-27b transcription during fetal distress and increases the sensitivity of neurons to hypoxia-induced apoptosis.

Authors:  Qun Chen; Fan Zhang; Yanbo Wang; Zhengya Liu; Anyang Sun; Ke Zen; Chen-yu Zhang; Qipeng Zhang
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

6.  The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.

Authors:  Olga Aprelikova; Kenny Chen; Lara H El Touny; Constance Brignatz-Guittard; Justin Han; Tinghu Qiu; Howard H Yang; Maxwell P Lee; Min Zhu; Jeffrey E Green
Journal:  Clin Epigenetics       Date:  2016-04-14       Impact factor: 6.551

7.  Protective effect of c-Myc/Rab7a signal pathway in glioblastoma cells under hypoxia.

Authors:  Chenguang Li; Yuanjian Fang; Kaikai Wang; Wei Gao; Zhangqi Dou; Xiaoyu Wang; Sheng Zhang; Cameron Lenahan; Xiaohua Wu
Journal:  Ann Transl Med       Date:  2020-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.